 |
FDA Drug Safety Podcasts
Podcasts by Topic
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
- Albuterol Inhalers
- September 26, 2008
- May 30, 2008
- Antiepileptic Drugs;
Suicidal Thoughts and Behavior
- Aranesp
- March 13, 2007
- November 8, 2007
C
- Codeine Side-Effects in Nursing Infants
- Colistimethate (marketed as Coly-Mycin M and generic products)
- Cough and Cold Products (Over-the-Counter (OTC)) in Infants and Children
D
- Darbepoetin alfa (marketed as Aranesp)
- March 13, 2007
- November 8, 2007
E
- Edetate Disodium (marketed as Endrate and generic products)
- Epoetin alfa (marketed as Procrit, Epogen)
- March 13, 2007
- November 8, 2007
- Epogen
- March 13, 2007
- November 8, 2007
- Erythropoiesis Stimulating Agents (ESAs)
- March 13, 2007
- November 8, 2007
F
- Fentanyl Transdermal System (Patch)
- Formoterol fumarate inhalation powder
H
- Heparin Sodium Injection (Baxter)
I
- Important Warnings and Instructions for Heparin Sodium Injection (Baxter)
- Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension
- Interferon gamma-1b (marketed as Actimmune)
N
- Nonprescription Cough and Cold Medicine Use in Children
O
- Over-the-Counter (OTC) Cough and Cold Products in Infants and Children
P
- Pergolide (marketed as Permax)
- Procrit
- March 13, 2007
- November 8, 2007
S
- Safe Use of Fentora (fentanyl buccal tablets)
T
- Tegaserod maleate (marketed as Zelnorm)
- Tiotropium bromide inhalation powder
- Transition from Chlorofluorocarbon (CFC) Propelled Albuterol Inhalers to Hydrofluroalkane (HFA) Propelled Albuterol Inhalers
- Tussionex Pennkinetic Extended-Release Suspension
U
V
- Varenicline (marketed as Chantix)
W
- Welcome from Dr. von Eschenbach
Z
 Back
to Top 
Back to FDA Drug Safety Podcasts
 PDF requires the free Adobe
Acrobat Reader
Date created: February 6, 2007; updated December 19, 2008 |
|
